Hugh Wang
Director - Bioinformatics Summit Plc
Hugh (Zhengyuan) Wang is Director of Bioinformatics at Summit Therapeutics, a role held since October 2021. Previously, he was Associate Director, Bioinformatics at Ambry Genetics, Principal/Senior Bioinformatics Scientist at AbbVie, and held earlier roles at Genomic Health, Kyowa Hakko Kirin and AnaptysBio.
Seminars
Friday 19th March 2027
Panel Discussion: Detecting & Tracking Acquired Resistance Mutations to Expedite Clinical Decision-Making
2:00 pm
- Establishing monitoring intervals frequent enough to catch resistance emergence before clinical progression
- Distinguishing true resistance signal from clonal noise to avoid switching therapy on a false trigger
- Building switch criteria into protocols so molecular progression is an actionable endpoint, not an observation
